Unnatural amino acids increase sensitivity and provide for the design of highly selective caspase substrates

Cell Death and Differentiation

Volumn 21, Issue 9, 2014, Pages 1482-1492

  Poreba, M ^a   Kasperkiewicz, P ^a   Snipas, S J ^b   Fasci, D ^b   Salvesen, G S ^b   Drag, M ^a,b  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CASPASE; PEPTIDE; PEPTIDE LIBRARY;

CHEMISTRY; CONFORMATION; ENZYME SPECIFICITY; HUMAN; METABOLISM; PEPTIDE LIBRARY; SYNTHESIS;

AMINO ACIDS; CASPASES; HUMANS; MOLECULAR CONFORMATION; PEPTIDE LIBRARY; PEPTIDES; SUBSTRATE SPECIFICITY;

EID: 84905901067     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.64     Document Type: Article

References (30)

1. McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 2013; 5: a008656.
2. Crawford ED, Wells JA. Caspase substrates and cellular remodeling. Annu Rev Biochem 2011; 80: 1055-1087.
3. Pop C, Salvesen GS. Human caspases: activation, specificity, and regulation. J Biol Chem 2009; 284: 21777-21781.
4. Shi Y. Mechanical aspects of apoptosome assembly. Curr Opin Cell Biol 2006; 18: 677-684.
5. van Raam BJ, Salvesen GS. Proliferative versus apoptotic functions of caspase-8 Hetero or homo: the caspase-8 dimer controls cell fate. Biochim Biophys Acta 2012; 1824: 113-122.
6. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997; 272: 17907-17911.
7. Rano TA, Timkey T, Peterson EP, Rotonda J, Nicholson DW, Becker JW et al. A combinatorial approach for determining protease specificities: application to interleukin- 1beta converting enzyme (ICE). Chem Biol 1997; 4: 149-155.
8. Poreba M, Strozyk A, Salvesen GS, Drag M. Caspase substrates and inhibitors. Cold Spring Harb Perspect Biol 2013; 5: a008680.
9. Linton SD. Caspase inhibitors: a pharmaceutical industry perspective. Curr Top Med Chem 2005; 5: 1697-1717.
10. MacKenzie SH, Schipper JL, Clark AC. The potential for caspases in drug discovery. Curr Opin Drug Discov Dev 2010; 13: 568-576.
11. Callus BA, Vaux DL. Caspase inhibitors: viral, cellular and chemical. Cell Death Differ 2007; 14: 73-78.
12. McStay GP, Salvesen GS, Green DR. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ 2008; 15: 322-331.
13. Benkova B, Lozanov V, Ivanov IP, Mitev V. Evaluation of recombinant caspase specificity by competitive substrates. Anal Biochem 2009; 394: 68-74.
14. Pereira NA, Song Z. Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity. Biochem Biophys Res Commun 2008; 377: 873-877.
15. Berger AB, Sexton KB, Bogyo M. Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity. Cell Res 2006; 16: 961-963.
16. Sleath PR, Hendrickson RC, Kronheim SR, March CJ, Black RA. Substrate specificity of the protease that processes human interleukin-1 beta. J Biol Chem 1990; 265: 14526-14528.
17. Howard AD, Kostura MJ, Thornberry N, Ding GJ, Limjuco G, Weidner J et al. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha. J Immunol 1991; 147: 2964-2969.
18. Maly DJ, Leonetti F, Backes BJ, Dauber DS, Harris JL, Craik CS et al. Expedient solidphase synthesis of fluorogenic protease substrates using the 7-amino-4-carbamoylmethylcoumarin (ACC) fluorophore. J Org Chem 2002; 67: 910-915.
19. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D et al. Substrate specificities of caspase family proteases. J Biol Chem 1997; 272: 9677-9682.
20. Boucher D, Blais V, Denault JB. Caspase-7 uses an exosite to promote poly(ADP ribose) polymerase 1 proteolysis. Proc Natl Acad Sci USA 2012; 109: 5669-5674.
21. Fuentes-Prior P, Salvesen GS. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 2004; 384(Pt 2): 201-232.
22. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-489.
23. Jiang X, Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem 2000; 275: 31199-31203.
24. Denault JB, Eckelman BP, Shin H, Pop C, Salvesen GS. Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9. Biochem J 2007; 405: 11-19.
25. Riedl SJ, Salvesen GS. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 2007; 8: 405-413.
26. Stennicke HR, Deveraux QL, Humke EW, Reed JC, Dixit VM, Salvesen GS. Caspase-9 can be activated without proteolytic processing. J Biol Chem 1999; 274: 8359-8362.
27. Ng NM, Pike RN, Boyd SE. Subsite cooperativity in protease specificity. Biol Chem 2009; 390: 401-407.
28. Stennicke HR, Salvesen GS. Caspases: preparation and characterization. Methods 1999; 17: 313-319.
29. Boatright KM, Deis C, Denault JB, Sutherlin DP, Salvesen GS. Activation of caspases 8 and 10 by FLIP L. Biochem J 2004; 382(Pt 2): 651-657.
30. Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM et al. A unified model for apical caspase activation. Mol Cell 2003; 11: 529-541